Intellectual Property Law and Copyright Laws

Subscribe
Intellectual property law and copyright law thought leadership, articles, podcasts, videos and webinars from expert sources across the legal world. Explore insights covering topics such as licensing and syndication, patent law, trade secrets and trademark law.
Article
Federal Circuit Affirms No Infringement in Pharmaceutical Patent Dispute Over pH Measurement Conditions For Epoprostenol Composition
The Federal Circuit's recent decision in Actelion Pharmaceuticals Ltd v. Mylan Pharmaceuticals Inc. examines critical questions about how pH measurements in pharmaceutical patent claims should be interpreted and applied. The court's analysis addresses whether pH should be measured at standard laboratory temperature or at the actual operating temperature during manufacturing, with significant implications for both literal infringement and doctrine of equivalents theories.
United States IP
AO
A&O Shearman
Article
PTAB/USPTO Update - October 2026
The USPTO has released new templates and guidance for AIA trial proceedings, announced key appointments including a Chief AI Officer, and published updated procedures for patent applications and subject matter eligibility declarations. Director Squires delivered multiple addresses emphasizing the constitutional importance of intellectual property rights while the agency expanded its community engagement efforts and international collaboration through WIPO's Global IP Assignment Platform pilot program.
United States IP
W
WilmerHale
See more
Article
Federal Circuit Clarifies Patent Marking Requirements For Settlement Licenses
The Federal Circuit's decision in VDPP, LLC v. Volkswagen Group of America, Inc. establishes critical obligations for patent owners regarding marking requirements when licensing their patents. Patent owners must now demonstrate reasonable efforts to ensure licensees comply with marking statutes, even in settlement agreements that don't explicitly admit infringement. Understanding these requirements is essential for both patent holders seeking to preserve pre-suit damages and alleged infringers evaluating po
United States IP
DLA Piper
Article
Beyond Hikma: Patent Prosecution Strategies For Anticipating Skinny-Label Generics In Pharmaceutical Patent Portfolios
The Supreme Court's Hikma decision has renewed focus on protecting patented pharmaceutical methods of treatment against generic "skinny labels." This article examines strategic lessons for innovative drug companies in patent prosecution and portfolio development to reduce risks associated with generic label carve-outs and strengthen competitive positioning in the regulatory framework.
United States IP
FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
See more
Article
PTAB/USPTO Update - October 2026
The USPTO has released new templates and guidance for AIA trial proceedings, announced key appointments including a Chief AI Officer, and published updated procedures for patent applications and subject matter eligibility declarations. Director Squires delivered multiple addresses emphasizing the constitutional importance of intellectual property rights while the agency expanded its community engagement efforts and international collaboration through WIPO's Global IP Assignment Platform pilot program.
United States IP
W
WilmerHale
See more
Article
Federal Circuit Affirms No Infringement in Pharmaceutical Patent Dispute Over pH Measurement Conditions For Epoprostenol Composition
The Federal Circuit's recent decision in Actelion Pharmaceuticals Ltd v. Mylan Pharmaceuticals Inc. examines critical questions about how pH measurements in pharmaceutical patent claims should be interpreted and applied. The court's analysis addresses whether pH should be measured at standard laboratory temperature or at the actual operating temperature during manufacturing, with significant implications for both literal infringement and doctrine of equivalents theories.
United States IP
AO
A&O Shearman
Article
PTAB/USPTO Update - October 2026
The USPTO has released new templates and guidance for AIA trial proceedings, announced key appointments including a Chief AI Officer, and published updated procedures for patent applications and subject matter eligibility declarations. Director Squires delivered multiple addresses emphasizing the constitutional importance of intellectual property rights while the agency expanded its community engagement efforts and international collaboration through WIPO's Global IP Assignment Platform pilot program.
United States IP
W
WilmerHale
See more
See more

Upcoming Events